Cura Cannabis Is Producing Montel Williams’ CBD Line For National Distribution
West Coast cannabis-oil producer Cura Cannabis has teamed up with Lenitiv Labs and founder Montel Williams to market Williams’ personal line of cannabidiol (CBD) products in most U.S. states.
The ambitious Portland-based firm announced today that it has begun producing Lenitiv Labs’ hemp-derived CBD capsules, which can now be ordered and shipped around the country.
According to Williams, Lenitiv’s ‘Alert’ and ‘Relax’ CBD capsules are 100% free of THC, the chemical in marijuana that’s responsible for many or most of its psychoactive effects (unlike CBD). The blends are also reportedly formulated with hand-picked terpenes known to help with anxiety, depression, pain management, inflammation, and/or memory retention as appropriate.
Cura, which produces the Select brand of concentrated cannabis oils and cartridges, said in a release that it will also begin production of Lenitiv’s cannabis-derived line to deliver “a number of new products this summer in Oregon and California in compliance with relevant state laws.”
Cura Cannabis’ Select CBD products for humans and pets are displayed on the company’s website. . [+] (Image via Cura Cannabis)
(Image via Cura Cannabis)
David Racz, CEO of Lenitiv Scientific, said in a statement, “When I partnered with Montel to help him make his patient-focused vision a reality, we realized we would need like-minded partnerships that understood and shared the values that underpin it. Cura not only shares that vision but expresses it in their culture.”
Williams, a former TV-host and frequent advocate for veteran and patient access to medical marijuana, explained by phone last year that he spent years working to develop medicinal-quality CBD to treat his own multiple sclerosis (MS), which research has shown responds well to the cannabinoid chemical.
After he was diagnosed in 1999, he soon exhausted every traditional treatment option for pain, stiffness, and other symptoms, Williams said. Then his M.D. mentioned marijuana.
“A credible doctor told me not to stick a needle in myself every day, not to take four pills a day, but to try cannabis,” he commented last spring. “It took about two and a half months to switch over, and I’ve had cannabis in my system every day since–except for about 40 when I was traveling in a country that strictly prohibits cannabis.”
“When we first began talking to Montel and his team at Lenitiv, we were drawn to their people-focused vision,” said Cameron Forni, Cura’s President and co-Founder, in a statement. ” It’s also an opportunity for us to support and participate in Montel’s advocacy for common sense cannabis reform, and we’re thrilled to welcome Montel and the team at Lenitiv to our family.”
Interestingly enough, since Lenitiv Labs was launched last year, another direct-to-consumer CBD oil operation appeared that claimed or insinuated to be selling Williams’ CBD products — an erroneous pretense that was promoted using images and phrases taken from Williams and myself without our permission.
After months of digging, attorneys for Williams tracked down some of the parties involved in selling what may or may not have been CBD oil, and litigation continues at present.
But starting today, his actual products are available to order online for real. You can quote me on that.
Montel Williams’ Lenitiv Scientific And Cura Cannabis Solutions Announce Deal To Produce Williams’ Lenitiv line
PORTLAND, Ore.–( BUSINESS WIRE )–Cura, a leading provider of cannabis oil, has reached an agreement to produce a hemp-derived and a cannabis-derived line for Lenitiv. Today, Lenitiv’s hemp-derived CBD Capsules are available online and can be shipped widely. The product was developed and formulated by media personality and Multiple Sclerosis (MS) survivor Montel Williams—one of the highest-profile medical cannabis patients in the United States.
Shortly before his diagnosis with MS in 1999, Williams had been on the set of Touched By An Angel filming an episode he guest starred in when his feet “caught fire.” Soon thereafter, Williams was diagnosed and learned that the all-consuming burning sensation in his feet was intractable neuropathic pain. After exhausting traditional remedies, Williams’ MS specialist, a neurologist, suggested he try medicinal cannabis, an idea he initially resisted, until he discovered that medical cannabis made the pain in his feet bearable. The Lenitiv brand benefits from Williams’ nearly two decades as a medical cannabis patient and was designed with his experience in mind.
Cura will produce Lenitiv products, starting with a hemp-derived CBD line, which launches nationwide today. Separately, Cura will produce Lenitiv’s cannabis-derived line which will be available with a number of new products this summer in Oregon and California in compliance with relevant state laws.
Lenitiv CBD Capsules are 100% hemp-derived and contain zero THC. Each bottle contains 30 gel capsules with 50mg of CBD each. Available in two options, Alert is designed to take in the morning, while Relax is designed to consume at night:
- Alert: Formulated with terpenes known to: aid anxiety, depression; pain management; act as an anti-inflammatory and soothe stress; promote alertness and memory retention
- Relax: Formulated with terpenes known to enhance mood, promote relaxation and restful sleep, quell anxiety, depression and insomnia; act as an antioxidant and anti-inflammatory.
“I’m excited to announce our agreement with Cura,” said David Racz, CEO of Lenitiv Scientific. “When I partnered with Montel to help him make his patient-focused vision a reality, we realized we would need like-minded partnerships that understood and shared the values that underpin it. Cura not only shares that vision but expresses it in their culture.”
Cura’s mission is to become the leading provider of cannabis oil in every market it enters and to become the first cannabis company with a billion-dollar valuation. Known for producing Select, the best-selling cannabis brand on the West Coast (CA/OR/NV, According to BDS Analytics), Cura looks forward to offering new and diverse products to the market through wholesale and white label agreements.
“When we first began talking to Montel and his team at Lenitiv, we were drawn to their people-focused vision,” said Cameron Forni, Cura’s President and co-Founder. “We’re really excited about this partnership because the values that underpin Lenitiv are synergistic with ours. It’s also an opportunity for us to support and participate in Montel’s advocacy for common sense cannabis reform, and we’re thrilled to welcome Montel and the team at Lenitiv to our family.”
Lenitiv CBD Capsules are available online and ship nationally. Visit www.lenitivproducts.com to purchase.
Cura Cannabis Solutions is one of the largest cannabis brands in America, on a mission to be the leading provider of cannabis oil in legal U.S. and international markets. Our goal is to provide patients and customers with the cleanest, most flavorful high quality cannabis oils, with the safest delivery method available. Makers of the Select Oil and Select CBD brands, Cura was established in Portland, Oregon in 2015 and in 2018, we were named #12 on Oregon Business Magazine’s list of the Top 100 Companies to Work For in Oregon. We expanded into California and Nevada in 2017, with new states on the horizon in 2018. Learn more at: www.curacan.com
ABOUT LENITIV SCIENTIFIC
Founded in 2016 by Montel Williams, Melanie McLaughlin and David Racz to make sure the needs of medical cannabis patients continue to be met in an increasingly adult-use market, Lenitiv is a premium brand that offers both hemp-derived CBD products nationwide and cannabis-derived products in Oregon, California and Nevada later this summer. Unlike many other “celebrity brands,” Williams is actively involved in Lenitiv, including as its chief formulator, taking advantage of his nearly two decades as a patient himself. Learn more at www.lenitivlabs.com